About this article Once-Weekly Semaglutide in Adults with Overweight or Obesity The New England Journal of Medicine (NEJM) (Mar 2021) Clinical Recommendations for the Management of Adverse Events Associated with Glucagon-Like Peptide-1 Receptor Agonists Journal of Clinical Medicine (Dec 2022) Notes:Article published
Gastrointestinal effects tend to be most pronounced when initiating therapy or increasing the dose, and many patients experience improvement as their bodies adjust to the medication
Using Semaglutide Safely with Hypothyroidism: A Monitoring Protocol Before Starting Semaglutide Before starting treatment, comprehensive diagnostic testing establishes a clear picture of your thyroid and metabolic health
This can happen from temperature fluctuations, expired peptide, or contamination
A recent New England Journal of Medicine study showed that although both these new drugs are highly effective, tirzepatide was shown to be more effective for weight loss, possibly because of the combination of these two hormone agonists when compared to the single hormone agonist in semaglutide
[PMID: 8372528] PubMed record related to this compound for laboratory literature review